Storia in 2 fonti

Summit pulls $500M share sale a day after announcing it

The developer of a leading PD-1/VEGF cancer drug cited “market conditions” for the cancellation. Its shares have struggled to break out following data milestones.

Raccontata da

biopharmadive.com

endpoints.news

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 mese fa

Summit pulls $500M share sale a day after announcing it

The developer of a leading PD-1/VEGF cancer drug cited “market conditions” for the cancellation. Its shares have struggled to break out following data milestones.

originale

endpoints.news1 mese fa

Summit withdraws $500M offering, citing 'market conditions'

The current biotech environment can apparently support an industry-record IPO and simultaneously hamper efforts to raise half a billion dollars.

Leggi questa versione → originale

Timeline cronologica

giovedì 11 giugno 2026·biopharmadive.com
Summit pulls $500M share sale a day after announcing it
The developer of a leading PD-1/VEGF cancer drug cited “market conditions” for the cancellation. Its shares have struggled to break out following data milestones.
giovedì 11 giugno 2026·endpoints.news
Summit withdraws $500M offering, citing 'market conditions'
The current biotech environment can apparently support an industry-record IPO and simultaneously hamper efforts to raise half a billion dollars.